Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20260604009Phase 4Not yet recruiting
Phase 4, randomised trial of tranexamic acid in endometrioma (2 arms), sponsored by Rajavithi Hospital. Primary endpoint: Postoperative hemoglobin level. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20260604009.